{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:55:25Z","timestamp":1758970525473},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/bf00685694","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T14:41:33Z","timestamp":1101652893000},"page":"384-390","source":"Crossref","is-referenced-by-count":18,"title":["Antitumor effects of ketoconazole and trifluoperazine in murine T-cell lymphomas"],"prefix":"10.1007","volume":"28","author":[{"given":"S.","family":"Naftalovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Yefenof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Eilam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"391","volume-title":"The pharmacological basis of therapeutics","author":"RJ Baldessarini","year":"1980","unstructured":"Baldessarini RJ (1980) Drugs for treatment of psychiatric disorders. In: Goodman LS, Gilman A, Gilman AG (eds) The pharmacological basis of therapeutics, tth edn. MacMillan, London, pp 391?447","edition":"tth edn."},{"key":"CR2","first-page":"6590","volume":"47","author":"Y Ben David","year":"1987","unstructured":"Ben David Y, Yefenof E, Kotler M (1987) Clonal analysis of radiation leukemia virus-induced leukemic and preleukemic cells. Cancer Res 47:6590?6594","journal-title":"Cancer Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000238554","volume":"34","author":"G Ben Gigi","year":"1988","unstructured":"Ben Gigi G, Polacheck I, Eilam Y (1988) In vitro synergistic activity of ketoconazole with trifluoperazine and with chlorpromazine against medical important yeasts. Chemotherapy 34:96?100","journal-title":"Chemotherapy"},{"key":"CR4","first-page":"133","volume-title":"The scientific basis of antimicrobial chemotherapy","author":"M Borgers","year":"1985","unstructured":"Borgers M (1985) Antifungal azole derivatives. In: Greenwood D, O'Grady F (eds) The scientific basis of antimicrobial chemotherapy. Cambridge University Press, Cambridge, pp 133?153"},{"key":"CR5","first-page":"133","volume":"46","author":"J Borsa","year":"1986","unstructured":"Borsa J, Einspenner M, Sargent MD, Hickie RA (1986) Selective cytotoxicity of calmidazolium and trifluoperazine for cycling versus noncycling C3H10T1\/2 cells in vitro. Cancer Res 46:133?136","journal-title":"Cancer Res"},{"key":"CR6","first-page":"208","volume":"27","author":"KM Bukowski","year":"1986","unstructured":"Bukowski KM, Murthy S, Budd GT, Purvis J, Ganapathi R (1986) Phase I\/II trial of doxorubicin (DOX) and trifluoperazine (TFP) in patients with clinical dexuribin resistance. Proc Am Assoc Cancer Res 27:208","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1073\/pnas.78.2.996","volume":"78","author":"JG Chafouleas","year":"1981","unstructured":"Chafouleas JG, Pardue RL, Brinkley BR, Dedman JR, Means AR (1981) Regulation of intracellular levels of calmodulin and tubulin in normal and transformed cells. Proc Natl Acad Sci USA 78: 996?1000","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0092-8674(82)90373-7","volume":"28","author":"JG Chafouleas","year":"1982","unstructured":"Chafouleas JG, Bolton WE, Hikaka H, Boyd AE, Means AR (1982) Calmodulin and the cell cycle: involvement in regulation of cell cycle progression. Cell 28:41?50","journal-title":"Cell"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(85)90251-X","volume":"II","author":"P Contreras","year":"1985","unstructured":"Contreras P, Auristella R (1985) Regression of metastatic adrenal carcinoma during palliative ketoconazole treatment. Lancet II: 151?152","journal-title":"Lancet"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/jcem-60-1-21","volume":"60","author":"P Contreras","year":"1985","unstructured":"Contreras P, Altieri E, Liberman C, Gac A, Rojas A, Ibarra A, Ravanal M, Seron-Ferre M (1985) Adrenal rest tumor of the liver causing Cushing's syndrome: treatment with ketoconazole preceding an apparent surgical cure. J Clin Endocrinol Metal 60:21?28","journal-title":"J Clin Endocrinol Metal"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.19.6.1073","volume":"19","author":"R Felice De","year":"1981","unstructured":"De Felice R, Johnson DC, Golgiani JW (1981) Gynecomastia with ketoconazole. Antimicrob Agents Chemother 19:1073?1074","journal-title":"Antimicrob Agents Chemother"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0015-0282(16)59649-6","volume":"49","author":"M DiMattina","year":"1988","unstructured":"DiMattina M, Loriaux DL, Maronian N, Albertson BD, Ashley H (1988) Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary. Fertil Steril 49: 62?65","journal-title":"Fertil Steril"},{"key":"CR13","first-page":"1063","volume":"134","author":"Y Eilam","year":"1988","unstructured":"Eilam Y, Chernichovski D (1988) Low concentrations of trifluoperazine arrest cell division cycle ofSaccharomyces cerevisiae at two specific stages. J Gen Microbiol 134:1063?1069","journal-title":"J Gen Microbiol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-104-1-123_2","volume":"104","author":"LD Feldman","year":"1986","unstructured":"Feldman LD (1986) Ketoconazole for male metastatic breast cancer. Ann Intern Med 104:123?124","journal-title":"Ann Intern Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-2952(88)90716-2","volume":"37","author":"R Ganapathi","year":"1988","unstructured":"Ganapathi R, Grabowski D (1988) Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular doxorubicin levels and expression of resistance. Biochem Pharmacol 37:185?193","journal-title":"Biochem Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/bjc.1988.214","volume":"58","author":"R Ganapathi","year":"1988","unstructured":"Ganapathi R, Schmidt H, Grabowski D, Melia M, Ratcliff N (1988) Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance. Br J Cancer 58:335?340","journal-title":"Br J Cancer"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0277-5379(89)90046-1","volume":"25","author":"F Grief","year":"1989","unstructured":"Grief F, Soroff HS, Albers KM, Taichman LB (1989) Effect of trifluoperazine, a calmodulin antagonist, on the growth of normal and malignant epidermal keratinocytes in culture. Eur J Cancer Clin Oncol 25:19?26","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0022-4731(88)90370-6","volume":"29","author":"JF Hackney","year":"1988","unstructured":"Hackney JF, Schwartz DA (1988) Ketoconazole inhibition and glucocorticoid action in the human lymphoblastic leukemia cell line CEM-C7. J Steroid Biochem 29:15?19","journal-title":"J Steroid Biochem"},{"key":"CR19","first-page":"202","volume":"14","author":"WN Hait","year":"1985","unstructured":"Hait WN, Grais L, Benz C, Cadman EC (1985) Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melitin. Cancer Chemother Pharmacol 14:202?205","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/bjc.1988.247","volume":"58","author":"AL Harris","year":"1988","unstructured":"Harris AL, Cantwell BMJ, Dowsett M (1988) High doses of ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer. Br J Cancer 58:493?496","journal-title":"Br J Cancer"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1139\/o83-119","volume":"61","author":"RA Hickie","year":"1983","unstructured":"Hickie RA, Wei J-W, Blyth LM, Wong DYW (1983) Cations and calmodulin in normal and neoplastic cell growth. Can J Biochem Cell Biol 61:934?941","journal-title":"Can J Biochem Cell Biol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0002-9343(86)90816-8","volume":"80","author":"FB Kraemer","year":"1986","unstructured":"Kraemer FB, Pont A (1986) Inhibition of cholesterol synthesis by ketoconazole. Am J Med 80:616?622","journal-title":"Am J Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1016\/0006-2952(86)90018-3","volume":"35","author":"A Lambert","year":"1986","unstructured":"Lambert A, Mitchell R, Robertson WR (1986) The effect of ketoconazole on adrenal and testicular steroidogenesis in vitro. Biochem Pharmacol 35:3999?4004","journal-title":"Biochem Pharmacol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF00293990","volume":"16","author":"S Lehnert","year":"1986","unstructured":"Lehnert S (1986) In vivo toxicity of phenothiazines to cells of a transplantable tumor. Cancer Chemother Pharmacol 16:296?272","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR25","first-page":"581","volume":"12","author":"RM Levin","year":"1976","unstructured":"Levin RM, Weiss B (1976) Mechanism by which psychotropic drugs inhibit adenosine cyclic 3?5?-monophosphate phosphodiesterase of brain. Mol Pharmacol 12:581?589","journal-title":"Mol Pharmacol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1172\/JCI110903","volume":"71","author":"DS Loose","year":"1983","unstructured":"Loose DS, Kan PB, Hirost MA, Marcus RA (1983) Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P-450-dependent enzymes. J Clin Invest 71:1495?1499","journal-title":"J Clin Invest"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0143-4160(88)90012-7","volume":"9","author":"AR Means","year":"1988","unstructured":"Means AR, Rasmussen CD (1988) Calcium, calmodulin and cell proliferation. Cell Calcium 9:313?319","journal-title":"Cell Calcium"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1200\/JCO.1988.6.5.880","volume":"6","author":"RL Miller","year":"1988","unstructured":"Miller RL, Bukowski RW, Budd GT, Purvis J, Weick JK, Shepard K, Midha KK, Ganapathi R (1988) Clinical modulation of doxorubicin resistance by the calmodulin inhibitor, trifluoperazine; a phase I\/II trial. J Clin Oncol 6:880?888","journal-title":"J Clin Oncol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0022-4804(88)90185-0","volume":"44","author":"PA Nardone","year":"1988","unstructured":"Nardone PA, Slotman GJ, Vezeridis MP (1988) Ketoconazole: a thromboxane synthetase and 5-lipoxygenase inhibitor with antimetastatic activity in B16-F10 melanoma. J Surg Res 44:425?429","journal-title":"J Surg Res"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0022-5347(17)44290-X","volume":"137","author":"A Pont","year":"1987","unstructured":"Pont A (1987) Long-term experience with high dose ketoconazole therapy in patients with stage D2 prostatic carcinoma. J Urol 137: 902?904","journal-title":"J Urol"},{"key":"CR31","first-page":"509","volume":"222","author":"WE Prozialek","year":"1982","unstructured":"Prozialek WE, Weiss B (1982) Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships. J Pharmacol Exp Ther 222:509?516","journal-title":"J Pharmacol Exp Ther"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/j.1460-2075.1989.tb03350.x","volume":"8","author":"CD Rasmussen","year":"1989","unstructured":"Rasmussen CD, Means AR (1989) Calmodulin is required for cell cycle progression during G1 and mitosis. EMBO J 8:73?82","journal-title":"EMBO J"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00264198","volume":"21","author":"CF Rochlitz","year":"1988","unstructured":"Rochlitz CF, Damon LE, Russi MB, Geddes A, Cadman EC (1988) Cytotoxicity of ketoconazole in malignant cell lines. Cancer Chemother Pharmacol 21:319?322","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0006-291X(82)90658-1","volume":"104","author":"Y Sasaki","year":"1982","unstructured":"Sasaki Y, Hidaka H (1982) Calmodulin and cell proliferation. Biophys Biochem Res Commun 104:451?456","journal-title":"Biophys Biochem Res Commun"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(89)90002-9","volume":"16","author":"DJ Stewart","year":"1989","unstructured":"Stewart DJ, Evans WK (1989) Non chemotherapeutic agents that potentiate chemotherapy efficacy. Cancer Treat Rev 16:1?40","journal-title":"Cancer Treat Rev"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-5347(17)49464-X","volume":"132","author":"J Trachtenberg","year":"1989","unstructured":"Trachtenberg J (1989) Ketoconazole therapy in advanced prostatic cancer. J Urol 132:61?63","journal-title":"J Urol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.17.6.922","volume":"17","author":"H Bossche Van den","year":"1980","unstructured":"Van den Bossche H, Willemsens G, Cools W, Cornelissen F, Lauwers WF, Van Cutsen JM (1980) In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol biosynthesis. Antimicrob Agents Chemother 17:922?928","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"CR38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00003495-198300251-00005","volume":"25","author":"G Wamplet","year":"1983","unstructured":"Wamplet G (1983) The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis. Drugs 25 [Suppl 1]:35?51","journal-title":"Drugs"},{"key":"CR39","first-page":"86","volume":"11","author":"JW Wei","year":"1983","unstructured":"Wei JW, Hickie RA, Klaassen DJ (1983) Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7 and W-13. Cancer Chemother Pharmacol 11:86?90","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(84)91253-4","volume":"II","author":"G Williams","year":"1984","unstructured":"Williams G (1984) Ketoconazole for prostate cancer. Lancet II:696","journal-title":"Lancet"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0171-2985(85)80006-1","volume":"169","author":"E Yefenof","year":"1985","unstructured":"Yefenof E, Feinman R, Kedar E (1985) Antigen nonspecific activities in culture supernatant of ovalbumin-specific cloned helper T lymphoma. Immunobiology 169:520?531","journal-title":"Immunobiology"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685694.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00685694\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:10:33Z","timestamp":1554459033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00685694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991]]}},"alternative-id":["BF00685694"],"URL":"https:\/\/doi.org\/10.1007\/bf00685694","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991]]}}}